Literature DB >> 1524353

[The bone marrow in human HIV infection. A bioptic study of 125 cases].

C Marche1, W Tabbara, L Matthiessen.   

Abstract

Bone marrow biopsies from 125 patients at different stages of HIV infection were examined and the histopathological changes are described. Indications for biopsy included peripheral blood abnormalities, search for opportunistic pathogens, a suspected lymphoma or evaluation of its progression. Common histopathological features, suggestive of HIV infection but non-pathognomonic, were: severe hypercellularity (43.2%), myelodysplasia (74.4%), plasmocytosis (86.4%), and lymphocytic (36.8%) and histiocytic infiltrates with or without granulomas (20%). Reticular fibrosis (58.6%), iron deposits (59.2%), vascular congestion and mucoid degeneration of fat (18.4%) were frequently observed. Hypoplasia was usually a late-occurring event and/or may have been iatrogenic. Opportunistic infections were detected in 8 patients: Mycobacterium avium intracellulare (4 cases), Mycobacterium tuberculosis (1 case), Cryptococcus neoformans (1 case), and Leishmania (1 case). Neoplastic complications were found in 3 patients: Burkitt's lymphoma (1 case) and Hodgkin's disease (2 cases). The pathophysiological mechanisms envisaged include the effect of HIV infection on precursor cells in the bone marrow.

Entities:  

Mesh:

Year:  1992        PMID: 1524353

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  2 in total

1.  Simultaneous occurrence of visceral leishmaniasis and disseminated histoplasmosis in an Italian patient with HIV infection.

Authors:  R Manfredi; A Mazzoni; S Pileri; G Marinacci; A Nanetti; S Poggi; F Chiodo
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

Review 2.  Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration.

Authors:  R Manfredi; A Mazzoni; A Nanetti; F Chiodo
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.